Remergent(R) Named Flagship Skin Care Line for California WellBeing Institute at Four Seasons Hotel Westlake Village
Posted on: Thursday, 8 February 2007, 06:00 CST
WESTLAKE VILLAGE, Calif., Feb. 8 /PRNewswire/ -- The California WellBeing Institute (CWI) - a unique lifestyle transformation center grounded in 21st century science - today announced the selection of REMERGENT(R) as their flagship skin care line. The Remergent(R) brand, based on the science of DNA repair enzymes, is a natural complement to the Institute's revolutionary approach to proactive overall health and wellbeing.
"Clinical studies suggest that DNA repair may be the key to reducing pre- cancerous cells and promoting overall healthy skin," says Ron Moy, MD, Former Co-Chief of the UCLA Division of Dermatology and Director of Dermatology at the CWI's clinic, the California Health and Longevity Institute. "I've recommended Remergent(R)'s DNA Repair Formula to my patients for over a year and believe it is one of the most promising products in skincare. The entire Remergent(R) line fits in nicely with our philosophy at CWI for progressive skin health."
As one of the prestigious physicians associated with the CWI clinic, Dr. Moy advocates a proactive protocol to optimum skin care. Dr. Moy stresses the importance of detecting pre-cancerous lesions and utilizes non-invasive methods for combating aging and sun damaged skin. The selection of the Remergent(R) brand aligns with the Institute's support of DNA science, in particular the pioneering use of proprietary DNA tests to analyze the rate of aging on a cellular level.
Available only from medical professionals, the Remergent(R) line is the first product line to use sophisticated formulas to target DNA repair, barrier re-building, pigmentary issues, discolorations from the sun and other skin concerns. The Remergent(R) DNA Repair Formula is a twice-a-day serum that encourages the skin to self-correct and, when used with a sunscreen, prevents future damage. Introduced in 2006 by AGI Dermatics, the 8-product line also features:
-- Barrier Repair Formula - designed to rebuild the skin's protective barrier from the inside out, boosts hydration and helps support repair of collagen -- A.M. Moisture SPF 15 - combines the best of two worlds: DNA repair enzymes (to cure past UV damage) and broad spectrum sunscreen (to protect against future damage) -- Antioxidant Refoliator - suitable for treating dehydrated skin from sunburn and exfoliation procedures such as chemical peels and laser treatments -- Microcirculation Therapy - aimed at increasing nitric oxide for treatment of under-eye darkness and fatigue
The CWI features a combination of unique facilities designed to create a life-changing experience, a solution-based focus to good health. Patrons enjoy the benefits of a state-of-the-art medical clinic as well as a science-based rejuvenation Spa, elegant workshop rooms, a healthy-eating demonstration kitchen and a fully-equipped fitness center. The entire facility sits on 20 acres in the foothills of Santa Monica, created in partnership with the Four Seasons Westlake Village.
For more information on the complete line of Remergent(R) products, please visit http://www.remergentskin.com/
Remergent(TM) is formulated by AGI Dermatics, the bio-pharmaceutical laboratory that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, AGI Dermatics specializes in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system, and cell-signaling in skin. The company's application of groundbreaking active ingredients and meticulously engineered liposome delivery systems is validated in controlled clinical studies and published in dozens of peer-reviewed scientific and medical journals. http://www.agiderm.com/
Remergent
CONTACT: Jill LaVorgna of RPR Marketing Communications, +1-212-317-1462,jill.lavorgna@rprny.com, for Remergent
Web site: http://www.remergentskin.com/http://www.agiderm.com/
Source: PRNewswire
Related Articles
- Brogan Wins $12 Million Federal Contract From National Institute of Environmental Health Sciences
- Philips and the Institute of Health Sciences Join Forces in Molecular Medicine
- USANA Health Sciences Expands Research Partnership With Renowned Linus Pauling Institute
- Gore Announces First Use of GORE Embolic Liquid to Occlude Cerebral Arteriovenous Malformation at Oregon Health & Science University
- Georgetown University Names Howard J. Federoff, MD, PhD, Executive Vice President for Health Sciences
- Noted Cardiologist Eric J. Topol to Lead New Scripps Translational Science Institute and Genomic Medicine Program
- C. Thomas Caskey Will Direct Brown Foundation Institute of Molecular Medicine at University of Texas Health Science Center
- University of Utah Health Sciences Selects AppSense to Lower Costs, Increase Performance of Critical Applications
- Tulane University Health Sciences Center in N.O. Receives Grant to Study Lung Disease
- The Immune Response Corporation and Oregon Health & Science University Collaboration Identifies FOXP3 As the Gene Marker for Impaired Immune Regulation in Multiple Sclerosis; Results May Lead to a New Therapeutic Approach to Treating MS
 |
 |
User Comments (0)
RSS Feeds